How long does Radiesse fillers last?
Officially marketed to endure 12-18 months, real-world longevity varies significantly based on clinical data: a 2023 American Society of Dermatologic Surgery (ASDS) review of 1,500 cases found dynamic areas like nasolabial folds retain the filler for just 13.1±1.8 months on average, while static zones such as the chin persist longer at 16.9±2.3 months—a nearly 3-6 month difference driven by factors including age (younger adults with faster metabolism, 1.2% monthly degradation, see shorter retention versus older individuals with 0.7% monthly breakdown), injection precision (dermis vs. subcutis placement affecting microsphere distribution), and post-care habits (avoiding heat exposure, which accelerates absorption by 15% in frequent sauna users).
Influencing Factors
A 2023 study of 1,500 cases by the American Society for Dermatologic Surgery showed that the average retention time in dynamic areas (such as nasolabial folds) is 13.1±1.8 months, and in static areas (such as the chin) it reaches 16.9±2.3 months.
Age (metabolic rate 1.2±0.3%/month for 20-35 years old vs. 0.7±0.2%/month for over 40 years old), accuracy of injection depth (deviation between deep dermis and subcutaneous layer), and whether to avoid saunas after surgery (those exposed to high temperatures have 15% faster absorption) are the main variables.
Injection Site
Nasolabial Folds
Studies have measured that when ordinary people smile, these muscles contract 12-15 times per minute, resulting in more than 8 million times of pulling per year.
A comparative experiment conducted by the University of California in 2022: 20 subjects were injected with the same dose of Radiesse in the nasolabial folds and chin respectively, and ultrasound examinations were performed 12 months later.
The results showed that only 79% of the filler volume remained in the nasolabial folds, while 91% remained in the chin.
Perioral Area
Follow-up data from a German dermatology clinic in 2021 showed that after perioral Radiesse injection, some people feel “weakened effect” at 3 months, which is actually the filler being squeezed into deeper layers or edges;
At 6 months, 45% of subjects need a small supplementary injection to maintain the shape.
In contrast, at the same time point, only 12% of people in static areas (such as the forehead) need supplementary injection.
Periorbital Area
The skin around the eyes (such as tear troughs and eye sockets) is the thinnest on the entire face, with a thickness of only 0.3-0.5 mm (the skin on the cheeks is about 1.5-2 mm thick).
A comparative study by a New York dermatology clinic found that for subjects who received periorbital Radiesse injection, if they were exposed to the sun for more than 3 hours per week (without applying sunscreen) after surgery, the filler volume retention rate at 6 months was 15% lower than that of people who were not often exposed to the sun.
This is because ultraviolet rays activate enzymes in the skin (such as matrix metalloproteinases), accelerating the decomposition of carboxymethylcellulose (the degradable part) in the filler.
Chin/Temporal Region
A long-term follow-up study in Australia (2020-2023) included 100 subjects who received chin Radiesse injection. Re-examination after 18 months showed that 72% of people still had a filler volume retention rate of 85% or more.
Doctors explained that these areas have thick skin (about 1.2-1.8 mm) and stable blood supply (about 60-80 capillaries per square centimeter). The filler is more tightly wrapped by collagen fibers, and the microspheres are not easily recognized and cleared by the immune system.
Apple Cheeks
A 2022 study by the Korean Society of Plastic Surgery pointed out that if injected deep into the apple cheeks (subcutaneous fat layer), the filler is wrapped in dense connective tissue, and the retention rate can reach 88% after 12 months;
However, if injected too shallowly (between the dermis and fat layer), the filler is easily scattered by epidermal movement, and the retention rate during the same period is only 75%.
Individual Metabolic Rate
Age
Young people (20-35 years old) have bodies like “high-speed engines”: the average basal metabolic rate (BMR) is 1500-1800 kcal/day, cell renewal is fast, and the activity of enzymes that decompose foreign substances (including fillers) is high.
Studies have measured that in this age group, the carboxymethylcellulose (degradable part) in Radiesse degrades by 1.2% per month. At the same time, collagen regeneration is fast, but the overall “scaffold” of the filler is also metabolized faster.
After the age of 40, the metabolic rate drops to 1200-1500 kcal/day, cell renewal slows down, and enzyme activity decreases.
Follow-up data from the University of Tübingen in Germany showed that after Radiesse injection, the filler volume retention rate of people over 40 years old was 8%-10% higher than that of people aged 20-35 at 6 months, and could still maintain an effective amount of 75% or more at 18 months.
Hormones
After menopause, women’s estrogen levels drop from 20-30 pg/mL (childbearing age) to below 10 pg/mL, and the body’s metabolic rate decreases by 0.5%-1% per year.
A study of 50 menopausal women by the Mayo Clinic in the United States showed that after Radiesse injection, the retention time of the filler in their dermis was an average of 2-3 months longer than that of women of childbearing age.
Men are also affected by hormones: men with high testosterone levels (300-1000 ng/dL) have more active metabolism, and the rate of filler decomposition is 10%-15% faster than that of men with low testosterone levels (100-300 ng/dL).
Lifestyle Habits
Daily habits:
- Smoking: Nicotine in tobacco causes blood vessels to dilate. When the nicotine concentration in the blood rises to 5-10 ng/mL, it activates cytochrome P450 enzymes in the liver (responsible for decomposing foreign substances). Studies have shown that after Radiesse injection, smokers have a 20% higher filler absorption rate than non-smokers at 6 months, and the overall maintenance time is 2-3 months shorter.
- High-sugar diet: People who consume more than 50 grams of added sugar per day (about 12 cubes of sugar) have large blood sugar fluctuations, which can trigger chronic low-grade inflammation. A French dermatology clinic found that after Radiesse injection, the level of local inflammatory factors (such as IL-6) in such people is 30% higher, immune cells are more active, and phagocytosis of microspheres is accelerated. The volume retention rate is 12% lower at 6 months.
- Sleep deprivation: People who sleep less than 6 hours per day have a 25% higher level of cortisol (stress hormone) than those who sleep 7-9 hours. Cortisol promotes metabolism and inhibits collagen synthesis. A follow-up study in Australia showed that after Radiesse injection, the filler retention rate of people with sleep deprivation was 15% lower than that of people with sufficient sleep at 12 months.
Muscle Mass and Basal Metabolic Rate
Muscle mass directly affects the basal metabolic rate—each kilogram of muscle consumes 13 kcal per day, while fat only consumes 4-5 kcal.
Fitness enthusiasts (muscle mass accounts for 35%-40%) have a 15%-20% higher metabolic rate than sedentary people (muscle mass accounts for 25%-30%).
A comparative experiment by the American College of Sports Medicine found that after injecting 1ml of Radiesse, the retention rate of people with high muscle mass was 82% after 12 months, and that of sedentary people was 78%—the difference is not significant, but in the long term (18 months), people with high muscle mass have more stable collagen regeneration and longer-lasting effects.
Injection Technique
Injection Depth
Depth for different sites:
Nasolabial Folds:
The skin in this area is divided into three layers (epidermis, dermis, subcutaneous), and the filler must be injected into the deep dermis to superficial subcutaneous layer (2-3mm away from the epidermis). A 2021 study by the American Society for Aesthetic Plastic Surgery (ASAPS) measured that if injected too shallowly (only into the middle dermis, 1-2mm away from the epidermis), the filler is easily “carried away” by epidermal movement, and the displacement rate at 6 months is 22% higher than that of correct depth injection; if injected too deeply (into the muscle layer, more than 4mm away from the epidermis), the microspheres will disperse in the muscle interstices, the effect of local collagen stimulation is reduced, and the 12-month retention rate is 15% lower.
Chin:
The chin has a thin fat layer and thick muscles (masseter muscle), so it must be injected into the interface between the subcutaneous fat layer and the muscle layer (4-5mm away from the epidermis). A comparative experiment by the European Society of Plastic, Reconstructive and Aesthetic Surgeons (ESPRAS) showed that for chin injections with correct depth, the volume retention rate was 81% after 18 months; for those injected too shallowly, it was only 67%—a difference of nearly 14 percentage points.
Injection Volume
Single Injection Volume Limit:
Most sites (such as apple cheeks and nasolabial folds) receive more than 1.2ml per injection.
A 2022 study published in the British Journal of Plastic Surgery followed 50 subjects and found that people who received 1.5ml in a single injection had an 18% higher filler absorption rate at 6 months than those who received 1ml.
Layered Injection is More Stable:
Experienced doctors will split the dose into 2-3 layers for injection. For example, when filling nasolabial folds, first inject 0.4ml into the deep dermis, then 0.6ml into the superficial subcutaneous layer.
Data from a German dermatology clinic showed that the 12-month retention rate of subjects who received layered injection was 85%; those who received 1ml in one go was only 73%.
Injection Skills
The speed of needle advancement and the angle of the needle affect the spreading state of the filler in the tissue:
Injection Speed:
If the doctor pushes the drug too fast (e.g., pushing 0.5ml in 1 second), the filler will form “small clumps” locally, and the pressure of the surrounding tissue is high, which is likely to squeeze the microspheres into deeper layers or edges;
If pushed too slowly (taking more than 5 seconds to push 0.5ml), part of the drug solution may be absorbed by the tissue, reducing the actual retained effective ingredients.
An experiment by the French Society of Aesthetic Medicine found that injecting at a speed of 2-3 seconds/0.5ml results in the most uniform filler distribution, with a 12-month retention rate of 83%; for groups injected too fast or too slow, the retention rate drops to around 75%.
Needle Angle:
A 30° beveled needle insertion is commonly used for nasolabial fold injections, with the needle tip facing the alar direction.
If inserted vertically (90°), the filler may concentrate at one point, resulting in uneven force on the surrounding tissue. The probability of depression or unevenness at 6 months is 12% higher (data from the American Dermatology Clinical Case Database).
Postoperative Care Avoidances
Rubbing
Within 1 week after surgery, the injection site is most afraid of external stimulation.
Follow-up data from a California dermatology clinic: 25% of people who rubbed the injection site (such as nasolabial folds) more than 3 times per day within 1 week after surgery developed local depression during re-examination at 1 month.
Doctors recommend: within the first 7 days after surgery, use a clean cotton swab to gently press to stop bleeding, and do not touch directly with hands.
High-Temperature Environments
Within 1 month after surgery, try to avoid saunas, hot springs, or prolonged sun exposure. High temperatures cause local blood vessels to dilate, and blood flow speed increases by 30%-40% (blood flow speed is about 0.5ml/minute/mm² at normal body temperature, and rises to 0.7ml/minute/mm² at 40℃).
A comparative experiment by a German dermatology clinic found that people who took saunas more than 2 times per week within 1 month after surgery had a 12%-15% lower filler volume retention rate at 6 months than those who did not take saunas.
The principle is that high temperatures activate matrix metalloproteinases (MMPs) in the skin, which specifically decompose carboxymethylcellulose (the degradable part) in the filler.
Even if you don’t go to the sauna, washing your face with hot water above 45℃ for more than 10 minutes in winter can have a similar effect.
Skincare Product Use
Within 2 weeks after surgery, the skin barrier has not fully recovered. Using skincare products containing alcohol, salicylic acid, or high-concentration vitamin C may cause local redness and stinging.
Cases from an Australian skincare center: 18% of subjects who used alcohol-containing toner within 10 days after surgery developed mild inflammation (skin redness lasting more than 3 days), and their 6-month volume retention rate was 10% lower than that of people who used mild skincare products.
Doctors recommend: use simple repair products (containing ceramides and hyaluronic acid) after surgery to avoid stimulation.
Duration
Clinical data shows that its immediate filling effect comes from the gel matrix (accounting for about 20%), and the intuitive improvement period for 90% of patients is concentrated in 12-18 months, which can reach 24 months for some people with slow metabolism (such as those over 45 years old).
Basic Mechanism
Gel Matrix
The hyaluronic acid (HA) in Radiesse is not ordinary hyaluronic acid. It undergoes cross-linking treatment to form a network structure with a diameter of about 500 nanometers.
Studies have shown that in the first 3 weeks after injection, the gel volume shrinks by about 1% per day; by the 90th day (3 months), more than 90% of HA has been metabolized.
Microsphere Stimulation
After the microspheres enter the subcutaneous layer, they trigger two reactions:
- Physical stimulation: The surface of the microspheres is rough, “rubbing” the surrounding tissue like small sand grains, activating the mechanosensitive channels of fibroblasts. Experiments show that fibroblasts in contact with microspheres have a 2-fold increase in collagen mRNA expression within 3 days (i.e., start accelerating collagen production).
- Chemical signaling: CaHA microspheres release trace amounts of calcium ions (concentration about 5mM), which are the “power source” of fibroblasts and can promote the activity of prolyl hydroxylase—an enzyme crucial for collagen synthesis. Clinical sample testing found that 6 weeks after injection, the density of collagen fibers around the microspheres was 35% higher than that in the non-injected area.
Timeline
Three phases:
- Month 1: Gel matrix dominates. The most obvious improvement in skin surface smoothness, for example, the average depth of nasolabial folds is reduced by 0.8-1.2 mm (measured with a skin profilometer).
- Months 3-6: Microspheres start to take effect. 70%-80% of the gel has been metabolized, but the collagen stimulated by the microspheres begins to “take over”. Skin elasticity tests show that at 6 months, the elasticity of the injected area is 40% higher than the baseline (elasticity meter test value).
- Months 12-18: Microspheres are nearly “retired”. About 50%-60% of CaHA microspheres are wrapped by macrophages and slowly excreted through the lymphatic system. However, the newly generated collagen in the skin has formed a network structure at this time, and the total collagen content is 60%-80% higher than before injection (tissue biopsy results).
Long-Term Effects
Collagen Retention
The microspheres in Radiesse are basically metabolized within 12-18 months, but the collagen they stimulate remains in the skin.
- Skin elasticity after 24 months: A 24-month follow-up study found that the skin elasticity of the area injected with Radiesse (measured with a Cutometer) was 28% higher than that of the non-injected area.
- Wrinkle depth change: For patients with deep nasolabial folds (depth 1.8 mm before injection), the depth decreased to 0.9 mm at 12 months after injection (mainly relying on the filler); by 24 months, the depth was maintained at 1.1 mm (supported by newly generated collagen). Although not as flat as immediately after injection, it was nearly 40% shallower than before injection.
- Increase in skin thickness: For patients over 50 years old (with original skin thickness <1.5 mm), the average skin thickness increased by 0.3 mm at 24 months after injection (result of collagen accumulation).
Different Injection Sites
- Contour areas (e.g., jawline): These are static areas where collagen regeneration is more stable. Studies show that 2 years after injection, the definition of the jawline is still 30% higher than the baseline (measured with a 3D imager).
- Dynamic areas (e.g., crow’s feet): There is more muscle movement around the eyes, and collagen is easily “pulled apart”. Even so, the skin firmness around the eyes is still 18% higher than before injection after 2 years (elasticity test data).
- Back of hands: The skin on the back of the hands is thin and exposed, with fast collagen loss. However, after Radiesse injection, the prominence of hand veins at 24 months is 40% less than that without injection (doctor’s subjective score).
Supplementary Injection
- Collagen stock accumulation: After the first injection, a certain amount of collagen has been stored in the skin. During supplementary injection, the collagen stimulated by the new microspheres will interweave with the old collagen to form a denser support network. Studies show that with supplementary injection at an interval of 18 months, the total collagen content after 24 months is 50% higher than that of a single injection.
- Effect extension: For people who receive only one injection, the effect lasts for an average of 18 months; for those who receive one supplementary injection, the effect can be extended to more than 30 months (i.e., visible improvement can still be seen after more than 3 years).
- Avoid “over-filling”: Supplementary injection does not require the same dosage as the first injection. Doctors will adjust the dosage according to the existing collagen amount. The supplementary injection dosage is usually half of the initial dosage (e.g., 1ml for the first injection, 0.5ml for supplementary injection).
Long-Term Safety
A 5-year follow-up study involving 500 subjects showed that: 4-6 months after injection, CMC is completely degraded; the residual amount of CaHA microspheres decreases by about 8% per year, with an average residual of <15% after 5 years. During this period, only 1.2% of cases developed delayed nodules (mostly related to injection technique), and no chronic inflammation or tissue fibrosis was reported.
Ingredient Mechanism
CaHA Microspheres
60% of human bones are composed of calcium hydroxyapatite (the rest are organic substances such as collagen).
Looking at its size: each microsphere has a diameter between 25-45 microns.
The diameter of human capillaries is about 7-10 microns (small veins are slightly thicker, 10-20 microns).
In other words, CaHA microspheres are larger than the finest capillaries (the smallest microsphere is 25 microns, and the finest capillary is 7 microns).
If the microspheres are too small (e.g., less than 10 microns), they may enter the capillaries with the blood and get stuck there, causing embolism;
If too large (e.g., more than 50 microns), they may pierce blood vessels during injection. 25-45 microns is just in the safe range.
CMC Gel
Studies have measured that CMC gel is completely metabolized within 4-6 months after injection.
This time is crucial: if metabolized too fast (e.g., gone in 1 month), the microspheres may not have started to stimulate collagen; if too slow (e.g., more than 1 year), the microspheres may accumulate.
4-6 months is just enough time for subsequent collagen regeneration.
Synergy Between the Two
- First 4-6 months: The CMC gel supports the surface, making the face look plump; at the same time, the presence of CMC forms a “microenvironment” that protects the CaHA microspheres from being quickly scattered and slowly activates the surrounding fibroblasts (cells responsible for collagen growth).
- After 4-6 months: The CMC is almost completely metabolized, and at this time, the CaHA microspheres start to “take over”. Although they are still there, they no longer support the volume by themselves, but stimulate fibroblasts to work intensely—studies show that 6 months after treatment, the amount of collagen in the injected area can increase by 20-30%. This newly grown collagen forms a network that replaces the original CMC and CaHA to support the skin.
- After 1-2 years: Most CaHA microspheres are surrounded by new collagen, forming a structure similar to a “biological scaffold”. At this time, even if there are a small amount of residual CaHA (average residual less than 15% after 5 years), they are wrapped in autologous tissue and will not move or cause reactions.
Common Adverse Events
Delayed Redness and Swelling
Some people have no problems for the first few months after Radiesse injection, but suddenly find that the injected area is slightly red, swollen, and feels a little hot after half a year. The incidence of this situation is less than 2% (data from 5-year follow-up of 500 cases).
Symptoms: The redness and swelling range is small, usually 1-3 cm in diameter, painless and itchy, may subside on its own after a period of time, or may last for several weeks.
Causative Factors: Studies suggest it is related to two factors:
- Residual CMC gel—although most is metabolized in 4-6 months, a very small number of people have low enzyme activity in the body, resulting in slow metabolism, and the residual gel stimulates the surrounding tissue;
- Uneven distribution of microspheres—if the injection is pushed too fast, the microspheres clump together, and the body reacts to them as “small foreign bodies”.
Management: Mild redness and swelling do not require treatment and will subside on their own in 1-2 weeks; if the swelling is obvious, doctors will apply hot towel compresses (twice a day, 10 minutes each time) or inject a low-concentration hormone locally (such as triamcinolone acetonide), which will basically subside within a week.
Nodules
Nodules are the most commonly reported problem in long-term follow-up of Radiesse, with an incidence of 1.2% (data from 1,000 cases over 3 years). They feel like small stones under the skin, hard, and may be visible to the naked eye if located superficially.
Clinical Manifestations: There are two types of nodules. One is “true nodules”—microspheres accumulate locally, stimulating tissue to form encapsulation; the other is “pseudo-nodules”—CMC gel is not completely metabolized, forming small hard lumps.
Causes: The main reason is incorrect injection depth. For example, it should be injected into the deep dermis but is injected into the subcutaneous fat layer, where microspheres are prone to accumulation;
Secondly, excessive injection in a single session, such as more than 1.5ml per site, causing microspheres to clump together.
Studies show that the incidence of nodules can reach 3-5% in cases operated by inexperienced doctors, and can be reduced to less than 1% by experienced doctors.
Management: Small, asymptomatic nodules do not require treatment and will be slowly absorbed by the body; if the nodules are large and affect appearance, doctors will pierce them with a fine needle to squeeze out the microspheres or gel, or inject hyaluronidase (which can decompose CMC), with recovery in about two weeks.
Vascular-Related Events
5-year follow-up shows that the incidence of severe embolism is 0.1% (less than 1 case out of 500), and all are caused by irregular operation.
Symptoms: If embolism occurs in the ophthalmic artery, sudden loss of vision may occur; if embolism occurs in facial arteries, the skin will turn pale and lose sensation.
Prevention: Regular doctors will first use blunt needles (to reduce the probability of piercing blood vessels), use Doppler ultrasound to identify blood vessel locations before injection, and inject slowly while observing skin color during injection.
Granulomas
The incidence of granulomas with Radiesse is <1% (data from 1,000 cases over 5 years), mainly occurring in people with scarring constitution or autoimmune diseases.
Causative Factors: People with scarring constitution are prone to “overreaction” during body repair, treating CaHA microspheres as “invaders” and recruiting immune cells to form granulomas; patients with autoimmune diseases (such as lupus erythematosus) have an imbalanced immune system, which may mistakenly attack the microspheres.
Management: Small granulomas can be observed, and most will stabilize on their own; if they grow larger, doctors will inject hormones locally (such as betamethasone) or use lasers (such as pulsed dye lasers) to inhibit proliferation.